Exosomes Market: Rapidly Evolving Industry…… COVID-19….
The global exosomes
market size
is expected to reach USD 2.28 billion by
2030, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 18.8% during the forecast
period. Nanovesicles, which play a major role in intercellular communication,
are anticipated to witness a significant rise in R&D, thus leading to
revenue growth in the coming years.
Biopharmaceutical innovators are at the
forefront of the human response to the coronavirus pandemic. A significant
number of major biotech firms are in the midst of a race to investigate the
Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the
speed of response to SARS/MERs etc, the biotech entities are investigating
SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are
being put into the R&D. With multiple candidates in trial, the public and
private sectors are anticipated to work in unison for the foreseeable period,
until a vaccine is developed for Covid-19. The report will account for Covid19
as a key market contributor.
Application of these vesicles as
carriers of functional content such as circulating nucleic acids, lipids, and
proteins can be attributed to market growth. In addition, exosomes play an
important role in immunosurveillance and tumor pathogenesis. Increasing
research programs focusing on determining the role of exosomes in
hepatocellular carcinoma (HCC) is estimated to drive the market.
Rising number of articles pertaining
to exosomal research is encouraging R&D activities in the field. Currently,
there are more than 4400 articles published about exosomes, with approximately
25% of these published in 2016 alone. In addition to the exponential rise in
article publication, number of companies engaged in the research is also
increasing.
These companies are taking advantage
of the natural propensity of exosomes for the transmission of macromolecule
payloads between cells. Application of these molecules in research activities
related to therapeutics and diagnostics is projected to result in exponential
growth in the coming years.
Moreover, increase in funding for
R&D in this field is poised to positively influence industrial growth. Rise
in funding capacity by public and private institutions is indicative of the
importance of exRNA molecules across the community engaged in translational
research pertaining to diagnostics and therapeutic product development.
To Request Sample Copy of this report, click the link:
Further key findings from the report suggest:
·
By workflow, downstream
analysis will account for a little over half the market revenue in 2030, due to
rising advancements in methods and instruments
·
Ultracentrifugation represented
the leading share in the isolation methods segment owing to higher adoption of
technology as compared to other methods of isolation. Immunocapture on beads is
anticipated to witness the fastest growth over the forecast period due to advancements
in lab-on-a-chip techniques
·
In 2016, cancer was the leading
application segment with a valuation of USD 1.15 million. Increasing
penetration of companies in oncology-based research on biomarker identification
is contributing to the growth of the segment
·
North America commanded the
dominant share in terms of market revenue due to presence of a large number of
academic and private organizations engaged in the launch of novel technologies
·
Major participants operating in
this sector include Takara Bio Company; Illumina, Inc.; Thermo Fisher
Scientific, Inc.; Fujifilm; and Qiagen. Strategies adopted by these
participants include patent filing, inauguration of certified production
facility, and launch of novel instruments.
The
global exosomes market size was estimated at USD 3.00 million in 2016. However,
exponential growth in revenue is anticipated over the coming decade due to
granular and bottom-up efforts made by researchers in the field. Rising number
of research grants and projects by various research organizations will also
contribute toward market growth.
Projects
are being undertaken to develop methods that enable efficient isolation and
characterization of exosomal vesicles. Participation of exosomes in different
functions and availability of a wide variety of pathways are expected to fuel
research in field, thereby leading to revenue generation. Rise in research
funding is also expected to boost the market in the coming years. For instance,
in August 2013, the U.S. National Institutes of Health announced the funding of
USD 17 million for 24 research projects focusing on extracellular RNA.
Small
companies flooding the marketplace and development of novel platforms and
advanced technologies will also drive market growth over the forecast period.
New platforms enable detection of low abundant membrane proteins and this
detection can be carried out even in the background of complex plasma proteins.
In
addition to this, the role of exosomes in providing insights for the diagnosis
of pathological conditions is anticipated to increase its adoption in the
research arena. Exosomes belong to the family of nanovesicles, which serve many
functions in the diagnosis and therapy of multiple diseases.
Browse Press
Release of this report:
Grand View Research has segmented the
global exosomes market on the basis of workflow, biomolecule type, application:
Exosomes Workflow Outlook (Revenue, USD Million,
2014 - 2030)
·
Isolation Methods
o Ultracentrifugation
o Immunocapture on beads
o Precipitation
o Filtration
·
Downstream Analysis
o Cell Surface Marker Analysis using Flow Cytometry
o Protein analysis using Blotting & ELISA
o RNA analysis with NGS & PCR
o Proteomic analysis using Mass Spectrometry
o Others
Exosomes Biomolecule Type Outlook (Revenue, USD Million,
2014 - 2030)
·
Non-coding RNAs
·
mRNA
·
Proteins /peptides
·
DNA fragments
·
Lipids
Exosomes Application Outlook (Revenue, USD Million, 2014
- 2030)
·
Cancer
·
Neurodegenerative diseases
·
Cardiovascular diseases
·
Infectious diseases
·
Others
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Comments
Post a Comment